AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: metabolic diseaseClear filter
industryMSN

Novo Nordisk’s OpenAI Deal Shows How Pharma Is Betting on AI at Scale

Novo Nordisk’s partnership with OpenAI points to a broader shift in pharma: major drugmakers are no longer testing AI at the margins, but embedding it into core discovery strategy. The deal also suggests that top-tier metabolic and chronic disease companies see AI as a competitive necessity, not just an innovation experiment.

Novo NordiskOpenAIdrug discoverypharma partnership
clinical

GLP-1 Expansion Story Is Getting More Practical: Comorbidities, Not Hype, Will Decide the Next Market

A new AJMC interview on GLP-1 medications points to continued interest in uses beyond weight loss, reflecting the drug class’s widening clinical and commercial ambition. The next phase, however, will depend less on broad enthusiasm than on disease-specific evidence, reimbursement logic, and tolerability in real-world populations.

AJMC
GLP-1obesitymetabolic disease

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.